A detailed history of Aqr Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 225,534 shares of REGN stock, worth $152 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
225,534
Previous 189,291 19.15%
Holding current value
$152 Million
Previous $199 Million 19.17%
% of portfolio
0.33%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $37.1 Million - $43.6 Million
36,243 Added 19.15%
225,534 $237 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $6.04 Million - $7.33 Million
6,839 Added 3.75%
189,291 $199 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $12.1 Million - $13.3 Million
-13,429 Reduced 6.86%
182,452 $176 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $4.43 Million - $5.04 Million
5,712 Added 3.0%
195,881 $172 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $20.4 Million - $24.9 Million
-29,481 Reduced 13.42%
190,169 $157 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $14.8 Million - $17.5 Million
-21,124 Reduced 8.77%
219,650 $158 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $46.5 Million - $56.5 Million
-68,381 Reduced 22.12%
240,774 $198 Million
Q4 2022

Feb 14, 2023

SELL
$705.89 - $766.39 $85.5 Million - $92.8 Million
-121,146 Reduced 28.15%
309,155 $223 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $68.9 Million - $87 Million
-120,115 Reduced 21.82%
430,301 $296 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $22.8 Million - $30.8 Million
41,635 Added 8.18%
550,416 $323 Million
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $35.2 Million - $41.3 Million
59,162 Added 13.16%
508,781 $355 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $94.3 Million - $116 Million
173,586 Added 62.89%
449,619 $284 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $47 Million - $55.8 Million
81,918 Added 42.2%
276,033 $167 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $45.6 Million - $53.9 Million
-96,546 Reduced 33.22%
194,115 $106 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $28.3 Million - $34.7 Million
-63,244 Reduced 17.87%
290,661 $138 Million
Q4 2020

Feb 16, 2021

SELL
$478.3 - $607.98 $53.2 Million - $67.6 Million
-111,199 Reduced 23.91%
353,905 $167 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $56.3 Million - $68 Million
103,282 Added 28.54%
465,104 $260 Million
Q2 2020

Aug 17, 2020

SELL
$493.32 - $643.92 $11.7 Million - $15.3 Million
-23,706 Reduced 6.15%
361,822 $223 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $14.3 Million - $21 Million
42,468 Added 12.38%
385,528 $179 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $13.2 Million - $18.1 Million
48,009 Added 16.27%
343,060 $129 Million
Q3 2019

Nov 14, 2019

SELL
$273.46 - $318.39 $15.3 Million - $17.8 Million
-55,846 Reduced 15.92%
295,051 $81.2 Million
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $9.87 Million - $13.7 Million
-32,960 Reduced 8.59%
350,897 $110 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $56.7 Million - $67 Million
152,469 Added 65.89%
383,857 $157 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $15.9 Million - $19 Million
47,207 Added 25.63%
231,388 $86.4 Million
Q3 2018

Nov 15, 2018

BUY
$351.14 - $408.51 $25.1 Million - $29.3 Million
71,623 Added 63.63%
184,181 $74.4 Million
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $50.9 Million - $61.7 Million
-178,740 Reduced 61.36%
112,558 $38.8 Million
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $62.4 Million - $77.8 Million
197,650 Added 211.06%
291,298 $100 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $16.3 Million - $21.4 Million
45,447 Added 94.29%
93,648 $35.2 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $20.8 Million - $24.3 Million
48,201
48,201 $21.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.